REMS Abuse Legislation: GPhA and PhRMA Set To Battle Again
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate bill would allow generic companies to bring civil suits against brand sponsors that use REMS requirements to avoid providing samples for testing.